118 hasil untuk "Yopp, Adam"
Menampilkan 1–20 · 0,42 detik · RSS
-
Artikel Jurnal Teks lengkap
The Utility of Anatomical Liver Resection in Hepatocellular Carcinoma: Associated with Improved Outcomes or Lack of Supportive Evidence?
Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related deaths worldwide. Surgical resection of HCC remains one of the mainstays of curative therapies and is associated with five-year overall survival rates approaching 60%. Despite improved perioperative outcomes, locoregional…
-
Artikel Jurnal Teks lengkap
Prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas
Intraductal papillary mucinous neoplasms (IPMN) are mucin producing cystic neoplasms of the pancreas histologically classified as having non-invasive and invasive components. The five-year survival rates for non-invasive and associated invasive carcinoma are 90% and 40%, respectively in resected…
-
Artikel Jurnal Teks lengkap
Laparoscopic liver resection for hepatocellular carcinoma: Indications and role
-
Artikel Jurnal Teks lengkap
Evolving thresholds for liver transplantation in hepatocellular carcinoma: A Western experience
Hepatocellular carcinoma (HCC) is the second leading cause of cancer‐related deaths worldwide. Once considered an experimental treatment with dismal survival rates, liver transplantation for HCC entered a new era with the establishment of the Milan criteria over 20 years ago. In the modern…
-
Artikel Jurnal Teks lengkap
Challenging the Treatment Paradigm: Selecting Patients for Surgical Management of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
Portal vein tumor thrombus (PVTT) remains a common presentation in patients with hepatocellular carcinoma (HCC). Approximately 30–50% of patients newly diagnosed with HCC will present with a concomitant PVTT. Current guidelines recommend systemic therapy for treatment of HCC with PVTT. Real-world…
-
Artikel Jurnal Teks lengkap
Perioperative antibiotic prophylaxis in pancreatoduodenectomy: toward a new standard, but questions remain
-
Artikel Jurnal Teks lengkap
Diagnostic Delays Are Common Among Patients With Hepatocellular Carcinoma
BACKGROUND: Most patients with hepatocellular carcinoma (HCC) present at advanced stages. The prevalence and clinical impact of delays during diagnostic evaluation among patients with HCC is unclear. PURPOSE: To identify and characterize factors associated with diagnostic delays among patients with…
-
Artikel Jurnal Teks lengkap
Screening Process Failures for Hepatocellular Carcinoma
More than 60% of patients with hepatocellular carcinoma (HCC) are diagnosed at a late stage, suggesting potential breakdowns in the HCC screening process. Understanding which steps in the screening process are not being performed is essential for designing effective interventions. To characterize…
-
Artikel Jurnal Teks lengkap
Primary Gastric Melanoma: Case Report of a Rare Malignancy
We report the case of a 64-year-old white male who presented to his primary care physician with complaints of fatigue. Physical exam was unremarkable and laboratory studies revealed profound anemia, for which the patient received a transfusion. Esophagogastroduodenoscopy revealed a bleeding mass in…
-
Artikel Jurnal Teks lengkap
Current issues and future trends in surveillance for hepatocellular carcinoma
-
Artikel Jurnal Teks lengkap
Development and Internal Validation of a Model for Early Detection of Hepatocellular Carcinoma in Patients with Cirrhosis
BACKGROUND: Surveillance for hepatocellular carcinoma (HCC) is recommended in patients with cirrhosis; however, early detection efforts are limited by suboptimal effectiveness. AIM: To derive and validate a model to accurately distinguish cirrhotic patients with and without HCC and compare the…
-
Artikel Jurnal Teks lengkap
Meta analysis: underutilization and disparities of treatment among patients with hepatocellular carcinoma in the united states
BACKGROUND: Despite wide availability of treatment options for hepatocellular carcinoma (HCC), several studies have suggested underutilization in clinical practice. AIMS: To quantify utilization rates for HCC treatment among patients with HCC in the United States and summarize patterns of…
-
Artikel Jurnal Teks lengkap
Hepatocellular Carcinoma Incidence is Decreasing Among Younger Adults in the United States
BACKGROUND & AIMS: Incidence rates for hepatocellular carcinoma (HCC) increased rapidly in the United States (US) since the 1990s, but have plateaued or started to decrease in other industrialized countries. It unclear if and when a similar trend will be observed in the US. We examined trends in…
-
Artikel Jurnal Teks lengkap
Role functioning is associated with survival in patients with hepatocellular carcinoma
BACKGROUND: Prior studies assessing quality of life (QOL) in patients with hepatocellular carcinoma (HCC) primarily included patients with preserved liver function and/or early HCC, leading to overestimation of QOL. Our study's aim was to evaluate the association of QOL with survival among a cohort…
-
Artikel Jurnal Teks lengkap
Clinical Efficiency and Safety Outcomes of Virtual Care for Oncology Patients During the COVID-19 Pandemic
Telehealth has been an integral response to the COVID-19 pandemic. However, no studies to date have examined the utility and safety of telehealth for oncology patients undergoing systemic treatments. Concerns of the adequacy of virtual patient assessments for oncology patients include the risk and…
-
Artikel Jurnal Teks lengkap
Racial and Ethnic Disparities in Barriers to Care in Patients with Hepatocellular Carcinoma
-
Artikel Jurnal Teks lengkap
Neoadjuvant and adjuvant systemic therapy in HCC: Current status and the future
Surgical therapies in patients with early-stage HCC can afford long-term survival but are often limited by the continued risk of recurrence, underscoring an interest in (neo)adjuvant strategies. Prior attempts at adjuvant therapy using tyrosine kinase inhibitors failed to yield significant…
-
Artikel Jurnal Teks lengkap
Racial and Ethnic Disparities in Survival Among Patients with Hepatocellular Carcinoma in the United States: A Systematic Review and Meta-Analysis
BACKGROUND AND AIMS: Hepatocellular carcinoma (HCC) is the fastest rising cause of cancer-related death in the United States; however, HCC incidence and mortality are not equally distributed among racial/ethnic groups. Our aim was to characterize the direction and magnitude of racial/ethnic…